These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 75457)

  • 41. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC; Chen JY; Glaser R; Henle W
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The purification and application of Epstein-Barr virus gp125].
    Wang G; Pi G; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
    Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
    Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
    Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
    Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
    Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.
    Chien YC; Chen JY; Liu MY; Yang HI; Hsu MM; Chen CJ; Yang CS
    N Engl J Med; 2001 Dec; 345(26):1877-82. PubMed ID: 11756578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of the Epstein-Barr virus P150 viral capsid antigen in Escherichia coli for the use as antigen in diagnostic tests].
    Fan JA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):381-7. PubMed ID: 2561513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
    Sam CK; Prasad U; Pathmanathan R
    Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
    Hutajulu SH; Ng N; Jati BR; Fachiroh J; Herdini C; Hariwiyanto B; Haryana SM; Middeldorp JM
    J Med Virol; 2012 May; 84(5):768-76. PubMed ID: 22431025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
    BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma and other neoplastic conditions.
    Kottaridis SD; Dafnou M; Besbeas S; Garas J
    J Natl Cancer Inst; 1977 Jul; 59(1):89-91. PubMed ID: 195074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M; Prasad U
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective study of Epstein-Barr virus antibody tetres and survival in patients with nasopharyngeal carcinoma.
    Chan SH; de Thé G; Goh EH
    Lancet; 1977 Apr; 1(8018):948-9. PubMed ID: 67401
    [No Abstract]   [Full Text] [Related]  

  • 59. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W; Cao SM; Huang QH; Li YH; Deng MQ
    Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
    Littler E; Baylis SA; Zeng Y; Conway MJ; Mackett M; Arrand JR
    Lancet; 1991 Mar; 337(8743):685-9. PubMed ID: 1672175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.